Reactive metabolites as a cause of late diabetic complications

Biochemical Society Transactions

Volumn 42, Issue 2, 2014, Pages 439-442

  Fleming, Thomas ^a   Nawroth, Peter P ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Advanced glycation end product (AGE); Diabetes; Diabetic neuropathy; Glyoxalase; Methylglyoxal; Sciatic nerve

Indexed keywords

GLYOXALASE; METHYLGLYOXAL; ADVANCED GLYCATION END PRODUCT; LACTOYLGLUTATHIONE LYASE;

ACTION POTENTIAL; ARTICLE; DIABETIC NEUROPATHY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HYPERSENSITIVITY; METABOLITE; MUSCLE CRAMP; NERVE ENDING; NOCICEPTION; PAIN; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SKIN TINGLING; ANIMAL; DIABETES COMPLICATIONS; DIABETIC NEUROPATHIES; HUMAN; METABOLISM; PATHOLOGY; SCIATIC NERVE;

ANIMALS; DIABETES COMPLICATIONS; DIABETIC NEUROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LACTOYLGLUTATHIONE LYASE; PYRUVALDEHYDE; SCIATIC NERVE;

EID: 84897003850     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20130265     Document Type: Article

References (39)

1. Callaghan, B.C., Cheng, H.T., Stables, C.L., Smith, A.L. and Feldman, E.L. (2012) Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 11, 521-534
2. Callaghan, B.C., Little, A.A., Feldman, E.L. and Hughes, R.A.C. (2012) Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst. Rev. 6, CD007543
3. Ismail-Beigi, F., Craven, T., Banerji, M.A., Basile, J., Calles, J., Cohen, R.M., Cuddihy, R., Cushman, W.C., Genuth, S., Grimm, Jr, R.H., Hamilton, B.P. et al. (2010) Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376, 419-430
4. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837-853
5. Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P.D., Zieve, F.J., Marks, J., Davis, S.N., Hayward, R., Warren, S.R. et al. (2012) Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129-139
6. Bongaerts, B.W.C., Rathmann, W., Kowall, B., Herder, C., Stöckl, D., Meisinger, C. and Zeigler, D. (2012) Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 study. Diabetes Care 35, 1891-1893
7. Lu, B., Hu, J., Wen, J., Zhang, Z., Zhou, L., Li, Y. and Hu, R. (2013) Determination of peripheral neuropathy prevalence and associated factors in Chinese subjects with diabetes and pre-diabetes: ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS). PLoS ONE 8, e61053
8. Fleming, T., Cuny, J., Nawroth, G., Djuric, Z., Humpert, P.M., Zeier, M., Bierhaus, A. and Nawroth, P.P. (2012) Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates? Diabetologia 55, 1151-1155
9. Thornalley, P.J., Jahan, I. and Ng, R. (2001) Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. J. Biochem. 129, 543-549 (Pubitemid 32299275)
10. Thurston, J.H., McDougal, D.B., Hauhart, R.E. and Schulz, D.W. (1995) Effects of acute, subacute, and chronic diabetes on carbohydrate and energy metabolism in rat sciatic nerve: relation to mechanisms of peripheral neuropathy. Diabetes 44, 190-195
11. Vlassara, H., Brownlee, M. and Cerami, A. (1981) Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Proc. Natl. Acad. Sci. U.S.A. 78, 5190-5192 (Pubitemid 12229699)
12. Vlassara, H., Brownlee, M. and Cerami, A. (1983) Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes 32, 670-674 (Pubitemid 13062852)
13. Williams, S.K., Howarth, N.L., Devenny, J.J. and Bitensky, M.W. (1982) Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus. Proc. Natl. Acad. Sci. U.S.A. 79, 6546-6550 (Pubitemid 13207531)
14. Cullum, N.A., Mahon, J., Stringer, K. and McLean, W.G. (1991) Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus. Diabetologia 34, 387-389
15. Sugimoto, K., Nishizawa, Y., Horiuchi, S. and Yagihashi, S. (1997) Localization in human diabetic peripheral nerve of Nε- carboxymethyllysine-protein adducts, an advanced glycation endproduct. Diabetologia 40, 1380-1387
16. Ryle, C. and Donaghy, M. (1995) Non-enzymatic glycation of peripheral nerve proteins in human diabetics. J. Neurol. Sci. 129, 62-68
17. Ryle, C., Leow, C.K. and Donaghy, M. (1997) Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus. Muscle Nerve 20, 577-584 (Pubitemid 27190749)
18. Sensi, M., Morano, S., Morelli, S., Castaldo, P., Sagratella, E., De Rossi, M.G., Andreani, D., Caltabiano, V., Verti, M., Purrello, F. and Di Mario, U. (1998) Reduction of advanced glycation end-product (AGE) levels in nervous tissue proteins of diabetic Lewis rats following islet transplants is related to different durations of poor metabolic control. Eur. J. Neurosci. 10, 2768-2775 (Pubitemid 29073950)
19. Thornalley, P.J., Battah, S., Ahmed, N., Karachalias, N., Agalou, S., Babaei-Jadidi, R. and Dawnay, A. (2003) Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem. J. 375, 581-592 (Pubitemid 37433506)
20. Bierhaus, A., Fleming, T., Stoyanov, S., Leffler, A., Babes, A., Neacsu, C., Sauer, S.K., Eberhardt, M., Schnölzer, M., Lasitschka, F., Neuhuber, W.L. et al. (2012) Methylglyoxal modification of Nav 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat. Med. 18, 926-933
21. Thornalley, P.J. (2003) Glyoxalase I: structure, function and a critical role in the enzymatic defence against glycation. Biochem. Soc. Trans. 31, 1343-1348
22. Jack, M.M., Ryals, J.M. and Wright, D.E. (2011) Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy. Diabetologia 54, 2174-2182
23. Jack, M.M., Ryals, J.M. and Wright, D.E. (2012) Protection from diabetes-induced peripheral sensory neuropathy: a role for elevated glyoxalase I? Exp. Neurol. 234, 62-69
24. Skapare, E., Konrade, I., Liepinsh, E., Strele, I., Makrecka, M., Bierhaus, A., Lejnieks, A., Pirags, V. and Dambrova, M. (2013) Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients. J. Diabetes Complications 27, 262-267
25. Groener, J.B., Reismann, P., Fleming, T., Kalscheuer, H., Lehnhoff, D., Hamann, A., Roser, P., Bierhaus, A., Nawroth, P.P. and Rudofsky, G. (2013) C332C genotype of glyoxalase 1 and its association with late diabetic complications. Exp. Clin. Endocrinol. Diabetes 121, 436-439
26. Peculis, R., Konrade, I., Skapare, E., Fridmanis, D., Nikitina-Zake, L., Lejnieks, A., Pirags, A., Dambrova, M. and Klovins, J. (2013) Identification of glyoxalase 1 polymorphisms associated with enzyme activity. Gene 515, 140-143
27. Morcos, M., Du, X., Pfisterer, F., Hutter, H., Sayed, A.A., Thornalley, P., Ahmed, N., Baynes, J., Thorpe, S., Kukudov, G., Schlotterer, A. et al. (2008) Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell 7, 260-269 (Pubitemid 351359658)
28. Schlotterer, A., Kukudov, G., Bozorgmehr, F., Hutter, H., Du, X., Oikonomou, D., Ibrahim, Y., Pfisterer, F., Rabbani, N., Thornalley, P.J., Sayed, A. et al. (2009) C. elegans as model for the study of high glucose-mediated life span reduction. Diabetes 58, 2450-2456
29. Mendler, M., Schlotterer, A., Morcos, M. and Nawroth, P.P. (2012) Understanding diabetic polyneuropathy and longevity: what can we learn from the nematode Caenorhabditis elegans? Exp. Clin. Endocrinol. Diabetes 120, 182-183
30. Stys, P.K. (2005) General mechanisms of axonal damage and its prevention. J. Neurol. Sci. 233, 3-13
31. Kapoor, R., Davies, M., Blaker, P.A., Hall, S.M. and Smith, K.J. (2003) Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann. Neurol. 53, 174-180 (Pubitemid 36163998)
32. Mack, T.G., Reiner, M., Beirowski, B., Mi, W., Emanuelli, M., Wagner, D., Thomson, D., Gillingwater, T., Court, F., Conforti, L., Fernando, F.S. et al. (2001) Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci. 4, 1199-1206 (Pubitemid 33135625)
33. Adalbert, R., Gillingwater, T.H., Haley, J.E., Bridge, K., Beirowski, B., Berek, L., Wagner, D., Grumme, D., Thomson, D., Celik, A., Addicks, K. et al. (2005) A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses. Eur. J. Neurosci. 21, 271-277 (Pubitemid 40193896)
34. Ikegami, K. and Koike, T. (2003) Non-apoptotic neurite degeneration in apoptotic neuronal death: pivotal role of mitochondrial function in neurites. Neuroscience 122, 617-626 (Pubitemid 37410283)
35. Sievers, C., Platt, N., Perry, V.H., Coleman, M.P. and Confortid, L. (2003) Neurites undergoing Wallerian degeneration show an apoptotic-like process with Annexin V positive staining and loss of mitochondrial membrane potential. Neurosci. Res. 46, 161-169 (Pubitemid 36593279)
36. Kennedy, J.M. and Zochodne, D.W. (2000) The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. Brain 123, 2118-2129
37. Xue, M., Rabbani, N., Momiji, H., Imbasi, P., Anwar, M.M., Kitteringham, N., Park, B.K., Souma, T., Moriguchi, T., Yamamoto, M. and Thornalley, P.J. (2012) Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation. Biochem. J. 443, 213-222
38. Xue, M., Qian, Q., Adaikalakoteswari, A., Rabbani, N., Babaei-Jadidi, R. and Thornalley, P.J. (2008) Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes 57, 2809-2817
39. Thornalley, P.J. (2005) The potential role of thiamine (vitamin B 1) in diabetic complications. Curr. Diabetes Rev. 1, 287-298